Related Experiment Video
Updated: Aug 6, 2026
09:07
Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Cepharanthine Inhibits Influenza A Virus Infection by Blocking Viral Attachment to Host Cells
Shan Chen1, Wenliang Pan2, Shuning Ren2
1College of Veterinary Medicine, Beijing University of Agriculture, Beijing, China.
Journal of Medical Virology
|July 17, 2026
Summary
Cepharanthine (CEP) effectively inhibits influenza A virus (IAV) infection by blocking viral attachment to cells. This natural compound offers broad-spectrum protection against IAV, showing promise for new antiviral drug development.
Area of Science:
- Virology
- Pharmacology
- Natural Products Chemistry
Background:
- Influenza A virus (IAV) poses a significant global health threat due to its transmissibility and pathogenicity.
- Rapid viral mutation and drug resistance necessitate novel anti-influenza therapeutics.
- Existing treatments face challenges from viral evolution and resistance.
Purpose of the Study:
- To investigate the antiviral potential of cepharanthine (CEP) against influenza A virus (IAV).
- To elucidate the mechanism of action of CEP in inhibiting IAV infection.
- To evaluate the therapeutic efficacy of CEP in a preclinical mouse model.
Main Methods:
- In vitro assays to assess CEP's inhibition of IAV replication across multiple subtypes.
- In vivo studies using a mouse model infected with a high dose of PR8 IAV.
- Analysis of CEP's effect on viral attachment, replication, cytopathic effects, and host cell viability.
- Investigation into whether CEP's mechanism involves modulation of the host innate immune response.
Main Results:
- Cepharanthine (CEP) demonstrated potent inhibition of IAV infection and replication in vitro.
- CEP treatment provided significant protection in mice infected with a high dose of PR8 IAV.
- CEP was found to block IAV attachment to host cell membranes, a novel mechanism of action.
- CEP treatment attenuated viral replication, reduced cytopathic effects, and enhanced cell viability.
- CEP's antiviral activity was independent of host innate immune response modulation.
Conclusions:
- Cepharanthine (CEP) exhibits broad-spectrum anti-IAV activity.
- CEP's primary mechanism involves blocking viral attachment to host cells.
- CEP shows significant therapeutic potential as a novel anti-influenza pharmaceutical.
More Related Videos
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
09:29Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Related Concept Videos
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...